Germany / Highest Honours for BioNTech Founders; Bayer’s Growth Predictions; Merck Making Further French Investments
A roundup of some of the most important recent news from German pharma, including state honours for the founders of…
BVMA
Last updated: 13.02.2014
Address: Rosenkavalierplatz 12, 81925 München,Germany
Tel: +49 (0)89 – 8 59 50 96
Web: http://www.bvma.de/
Company description
The “Bundesverband Medizinischer Auftragsinstitute” (BVMA) was founded in July 1991 in order to represent CROs (Contract Research Organisations) which are based in Germany or German speaking countries. The BVMA is based in Munich. As of April 2009 there are 26 member companies of the Association, operating in the field of clinical research at a national as well as international level.Companies (legal entities) offering services in the context of clinical research (such as planning/conducting/analysing clinical trials; quality assurance; laboratory services; regulatory affairs of medicinal products / medical devices) may become members, provided they have been operating commercially for at least two years and they meet the quality prerequisites which have been defined by the BVMA.In order to make sure that each member maintains the requirements of high quality, system audits are carried out every three years. The general meeting appoints an external organisation to carry out this task. This self-imposed measure guarantees continued high standards of all the member companieThe current President of the BVMA is Dr Dagmar Chase.
Products and services
Related
Germany / STADA’s Bold Bets on M&A
After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness…
Germany / The Biotech Behind Pfizer’s COVID-19 Vaccine Candidate
German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant…
Pharma Faces / Teresa Rodó, Head of Global Healthcare Operations, Merck
PharmaBoardroom recently sat down with Merck’s EVP and Head of Global Healthcare Operations, Teresa Rodó to…
Merck KGaA / Big-Ticket Investments in Manufacturing Scale & Digital Innovation
Merck KGaA has moved to continuously expand its manufacturing capacity and capability in recent years with a number…
Europe / A New Approach to Health Crises in France & Germany
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would…
News Roundup / German Pharma: February 2020
Some of the top recent stories from Germany, Europe’s leading pharma market according to CPhI, including big…
Bayer: Betting Big on Cell & Gene Therapy
Bayer’s latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as…
Merck Announces EUR 1 Billion HQ Investment
German giant Merck KGaA has announced a EUR one billion investment into its headquarters in Darmstadt, Germany up…
Interview with Elmar Schnee , President of Merck Serono and Member of the…
As a majority family owned group, Merck is also the oldest pharmaceutical company in the world and known throughout…
Interview with Andreas Fibig, CEO, Bayer Schering Pharma
The 2006 acquisition of Schering by Bayer is a prime example of the way that big pharma is now approaching growth…
Interview with Ralf Göddertz, General Manager of Germany, Austria and…
DAIICHI SANKYO in Germany, Austria and Switzerland DAIICHI SANKYO wants to be a Global Pharma Innovator with…
